Algo version: 0.98b
Sun Pharma Advanced is listed at the NSE Exchange
Sun Pharma Advanced [SPARC.NS]
NSE Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Sun Pharma Advanced stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Sun Pharma Advanced 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR151.40, you would have made a profit of INR74.32 per share or 49.09%

Yes, the average daily trading liquidity for Sun Pharma Advanced is INR873 805 thousand. You should therefore be able to get in and out of your positions relatively fast.

Sun Pharma Advanced has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.40, the company's ability to pay off the debt is normal. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Sun Pharma Advanced to be high [0.7 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.